Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

McClatchy Q4 Profit Rises - Quick Facts

RELATED NEWS
Trade MNI now with 

McClatchy Co. (MNI: Quote) reported that its fourth-quarter net income rose to $42.01 million or $0.49 per share, from $14.78 million or $0.17 per share in the same quarter last year.

Adjusted income from continuing operations increased to $43.21 million from $33.48 million in the year ago quarter.

Revenues for the quarter declined to $351.44 million from $369.93 million in the prior year quarter.

Analysts polled by Thomson Reuters expected the company to report earnings of $0.40 per share on revenues of $347.80 million for the quarter. Analysts' estimates typically exclude special items.

Click here to receive FREE breaking news email alerts for McClatchy Co and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Yeast bloodstream infections, which are caused by Candida species, are a type of fungal infection, and if untreated, can result in serious medical complications. People who have a weak immune system, or are hospitalized in intensive care units, or have kidney disease needing dialysis, or have had abdominal surgery are said to be at risk of developing yeast bloodstream infections. After moving mostly higher over the course of the previous week, stocks showed a notable move back to the downside during trading on Monday. With the drop on the day, the Dow pulled back well off last Friday's record closing high. After reporting four consecutive monthly increases, the National Association of Realtors released a report on Monday showing an unexpected drop in U.S. existing home sales in the month of August. NAR said existing home sales fell 1.8 percent to a seasonally adjusted annual rate of 5.05 million in August.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.